What predicts change in pulmonary function and quality of life in asthma or COPD?

被引:62
作者
Hesselink, A. E.
van der Windt, D. A. W. M.
Penninx, B. W. J. H.
Wijnhoven, H. A. H.
Twisk, J. W. R.
Bouter, L. M.
van Eijk, J. Th. M.
机构
[1] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Gen Practice, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands
[4] Maastricht Univ, Dept Med Sociol, Maastricht, Netherlands
关键词
asthma; chronic obstructive pulmonary disease (COPD); health-related quality of life; pulmonary function; longitudinal study;
D O I
10.1080/02770900600856954
中图分类号
R392 [医学免疫学];
学科分类号
100102 [免疫学];
摘要
Information about predictors of decline in pulmonary function (forced expiratory volume in 1 second [FEV1]) or health-related quality of life (HRQoL) in patients with asthma or (chronic obstructive pulmonary disease [ COPD]) might help to determine those who need additional care. A 2-year prospective cohort study was conducted among 380 asthma and 120 COPD patients. In both asthma and COPD patients, a 2-year change in FEV1 was only weakly associated with a 2-year change in HRQoL (r = .0.19 and 0.24, respectively). In both groups, older age, living in an urban environment, and a lower peak expiratory flow rate (PEFR) at baseline were associated with a decline in FEV1. Additional predictors of FEV1 decline were greater body weight, less chronic cough or sputum production, and less respiratory symptoms in asthma patients and current smoking in COPD patients. A decline in HRQoL was associated with older age, non-compliance with medication, more dyspnea, and a lower PEFR in asthma patients and with male gender, lower education, lower body weight, more dyspnea, and more respiratory symptoms in COPD patients. Our results show that FEV1 and HRQoL appear to represent different disease aspects influenced by different predictors.
引用
收藏
页码:513 / 519
页数:7
相关论文
共 27 条
[1]
*AM THOR SOC, 1995, STATEMENT AM THORAX, V1522, P1107
[2]
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[3]
Celli BR, 2000, CHEST, V117, P15
[4]
HEALTH-RELATED QUALITY-OF-LIFE AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
CURTIS, JR ;
DEYO, RA ;
HUDSON, LD .
THORAX, 1994, 49 (02) :162-170
[5]
Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases [J].
Fan, VS ;
Curtis, JR ;
Tu, SP ;
McDonell, MB ;
Fihn, SD .
CHEST, 2002, 122 (02) :429-436
[6]
Chronic obstructive pulmonary disease stage and health-related quality of life [J].
Ferrer, M ;
Alonso, J ;
Morera, J ;
Marrades, RM ;
Khalaf, A ;
Aguar, MC ;
Plaza, V ;
Prieto, L ;
Antó, JM .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (12) :1072-1079
[7]
GEIJER RMM, 2001, HUISARTS WETENSCHAP, V44, P107
[8]
GEIJER RMM, 2001, HUISARTS WET, V44, P153
[9]
Gibson P.G., 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001117, 10.1002/14651858.cd001117, DOI 10.1002/14651858.CD001117]
[10]
Quality of life and functional parameters in patients with chronic obstructive pulmonary disease (COPD): an update [J].
Gigliotti, F ;
Grazzini, M ;
Stendardi, L ;
Romagnoli, I ;
Scano, G .
RESPIRATORY MEDICINE, 2002, 96 (06) :373-374